463 related articles for article (PubMed ID: 25841633)
1. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.
Kawai K; Rampakakis E; Tsai TF; Cheong HJ; Dhitavat J; Covarrubias AO; Yang L; Cashat-Cruz M; Monsanto H; Johnson K; Sampalis JS; Acosta CJ
Int J Infect Dis; 2015 May; 34():126-31. PubMed ID: 25841633
[TBL] [Abstract][Full Text] [Related]
2. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
[TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
[TBL] [Abstract][Full Text] [Related]
4. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study.
Drolet M; Brisson M; Schmader K; Levin M; Johnson R; Oxman M; Patrick D; Camden S; Mansi JA
J Pain; 2010 Nov; 11(11):1211-21. PubMed ID: 20434957
[TBL] [Abstract][Full Text] [Related]
5. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study.
Mizukami A; Sato K; Adachi K; Matthews S; Holl K; Matsuki T; Kaise T; Curran D
Clin Drug Investig; 2018 Jan; 38(1):29-37. PubMed ID: 29086340
[TBL] [Abstract][Full Text] [Related]
6. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
[TBL] [Abstract][Full Text] [Related]
7. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
Han R; Gomez JA; de Veras B; Pinto T; Guzman-Holst A; Nieto J; van Oorschot DAM
Hum Vaccin Immunother; 2023 Dec; 19(1):2164144. PubMed ID: 36821856
[TBL] [Abstract][Full Text] [Related]
8. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory.
Coplan PM; Schmader K; Nikas A; Chan IS; Choo P; Levin MJ; Johnson G; Bauer M; Williams HM; Kaplan KM; Guess HA; Oxman MN
J Pain; 2004 Aug; 5(6):344-56. PubMed ID: 15336639
[TBL] [Abstract][Full Text] [Related]
9. Use of S-LANSS, a tool for screening neuropathic pain, for predicting postherpetic neuralgia in patients after acute herpes zoster events: a single-center, 12-month, prospective cohort study.
Cho SI; Lee CH; Park GH; Park CW; Kim HO
J Pain; 2014 Feb; 15(2):149-56. PubMed ID: 24342706
[TBL] [Abstract][Full Text] [Related]
10. Burden of illness, quality of life, and healthcare utilization among patients with herpes zoster in South Korea: a prospective clinical-epidemiological study.
Song H; Lee J; Lee M; Choi WS; Choi JH; Lee MS; Hashemi M; Rampakakis E; Kawai K; White R; Acosta C; Sampalis JS; Cheong HJ
Int J Infect Dis; 2014 Mar; 20():23-30. PubMed ID: 24412314
[TBL] [Abstract][Full Text] [Related]
11. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.
Takao Y; Miyazaki Y; Okeda M; Onishi F; Yano S; Gomi Y; Ishikawa T; Okuno Y; Mori Y; Asada H; Yamanishi K; Iso H
J Epidemiol; 2015; 25(10):617-25. PubMed ID: 26399445
[TBL] [Abstract][Full Text] [Related]
12. Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study.
Díez-Domingo J; Curran D; Cambronero MDR; Garcia-Martinez JA; Matthews S
Adv Ther; 2021 Jun; 38(6):3325-3341. PubMed ID: 34013498
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.
Lu WH; Lin CW; Wang CY; Chen LK; Hsiao FY
BMC Public Health; 2018 Mar; 18(1):369. PubMed ID: 29554872
[TBL] [Abstract][Full Text] [Related]
14. Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan.
Tung YC; Tu HP; Tsai WC; Chen CS; Su CH; Shi HY; Lin CL
PLoS One; 2015; 10(6):e0129043. PubMed ID: 26065420
[TBL] [Abstract][Full Text] [Related]
15. Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy.
Parruti G; Tontodonati M; Rebuzzi C; Polilli E; Sozio F; Consorte A; Agostinone A; Di Masi F; Congedo G; D'Antonio D; Granchelli C; D'Amario C; Carunchio C; Pippa L; Manzoli L; Volpi A;
BMC Med; 2010 Oct; 8():58. PubMed ID: 20937086
[TBL] [Abstract][Full Text] [Related]
16. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
18. Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study.
Bricout H; Perinetti E; Marchettini P; Ragni P; Zotti CM; Gabutti G; Volpi A; Franco E
BMC Infect Dis; 2014 Dec; 14():637. PubMed ID: 25479617
[TBL] [Abstract][Full Text] [Related]
19. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
[TBL] [Abstract][Full Text] [Related]
20. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
